Case Report

Elevation of the Tumor Marker CA125 in Right Heart Failure

Authors: Boban Mathew, MD, DM, MRCP, Vishal Bhatia, MD, I R Mahy, MD, FRCP, Imad Ahmed, MD, Lisa Francis, MBBS, MRCP

Abstract

Carbohydrate antigen 125, known as a marker for ovarian cancer, has been reported to be elevated in heart failure caused by left ventricular dysfunction. A case of elevated carbohydrate antigen 125 in isolated right heart failure due to atrial septal defect with preserved left ventricular function is reported.


Key Points


* Congestive heart failure is associated with elevated CA125, and is described in patients with left ventricular dysfunction and congestive heart failure.


* This patient is unique in that she had isolated right ventricular failure due to atrial septal defect, with normal left ventricular function.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Nagele H, Bahlo M, Klapdor R, et al. CA 125 and its relation to cardiac function. Am Heart J1999;137:1044–1049.
 
2. Soma L, Allen M, Tobin L, et al. CA-125 concentrations in patients awaiting cardiac transplantation.Clin Chem 2002;48:2289–2290.
 
3. D’Aloia A, Faggiano P, Aurigemma G, et al. Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis. J Am Coll Cardiol 2003;41:1805–1811.
 
4. Faggiano P, D’Aloia A, Bignotti T, et al. One biologic marker (carbohydrate antigen-CA 125), two different diseases (ovarian cancer and congestive heart failure): practical implications of monitoring CA 125 serum levels. A case report. Ital Heart J 2003;4:497–499.
 
5. Turk HM, Pekdemir H, Buyukberber S, et al. Serum CA 125 levels in patients with chronic heart failure and accompanying pleural fluid. Tumour Biol 2003;24:172–175.
 
6. Miralles C, Orea M, Espana P, et al. Cancer antigen 125 associated with multiple benign and malignant pathologies. Ann Surg Oncol 2003;10:150–154.
 
7. Eltabbakh GH, Belinson JL, Kennedy AW, et al. Serum CA-125 measurements > 65 U/mL. Clinical value. J Reprod Med 1997;42:617–624.